Study Title

First in Human Safety of [68Ga]-NOTA-hGZP- PET Imaging in Subjects Receiving Checkpoint Inhibitor Immunotherapy

Study Details

Description:

First in Human Safety of [68Ga]-NOTA-hGZP PET Imaging in subjects with cancer undergoing treatment with a checkpoint inhibitor either as a monotherapy of in combination I-O therapy

Sponsor:

Cytosite Biopharma Inc

Government Study Link:

NCT04169321 - Click here to see study on

ClinicalTrials.gov